Canadian Society of Allergy and Clinical Immunology: Guidelines for the use of allergen immunotherapy. Can Med Assoc J. 1995, 152: 1413-9.
Google Scholar
WHO position paper: Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998, 47: 698-704.
Google Scholar
Nelson HS: The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol. 2000, 106 (1 Pt 1): 41-5. 10.1067/mai.2000.107197.
Article
CAS
PubMed
Google Scholar
Lockey RF: "ARIA": global guidelines and new forms of allergen immunotherapy. J Allergy Clin Immunol. 2001, 108: 497-9. 10.1067/mai.2001.118638.
Article
CAS
PubMed
Google Scholar
Joint Task Force on Practice Parameters: Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2003, 90 (1 Suppl 1): 1-40.
Google Scholar
Jutel M, Pichler WJ, Skrbic D: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol. 1995, 154: 4187-94.
CAS
PubMed
Google Scholar
Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest. 1999, 103: 175-83. 10.1172/JCI5155.
Article
PubMed Central
CAS
PubMed
Google Scholar
Akdis CA, Blesken T, Akdis M: Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998, 102: 98-106. 10.1172/JCI2250.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jutel M, Akdis M, Budak F: IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003, 33: 1205-14. 10.1002/eji.200322919.
Article
CAS
PubMed
Google Scholar
Francis JN, Till SJ, Durham SR: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003, 111: 1255-61. 10.1067/mai.2003.1570.
Article
CAS
PubMed
Google Scholar
Lowell FC, Franklin W: A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med. 1965, 273: 675-9. 10.1056/NEJM196509232731302.
Article
CAS
PubMed
Google Scholar
Ohashi Y, Nakai Y, Tanaka A: Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg. 1998, 124: 1337-46.
Article
CAS
PubMed
Google Scholar
Ross RN, Nelson HS, Finegold I: Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther. 2000, 22: 342-50. 10.1016/S0149-2918(00)80038-7.
Article
CAS
PubMed
Google Scholar
Cantani A, Micera M: Is specific immunotherapy safe and effective in children?. Eur Rev Med Pharmacol Sci. 2000, 4: 139-43.
CAS
PubMed
Google Scholar
Pichler CE, Helbling A, Pichler WJ: Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy. 2001, 56: 301-6. 10.1034/j.1398-9995.2001.00834.x.
Article
CAS
PubMed
Google Scholar
Durham SR, Walker SM, Varga EM: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999, 341: 468-75. 10.1056/NEJM199908123410702.
Article
CAS
PubMed
Google Scholar
Des Roches A, Paradis L, Knani J: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996, 51: 430-3.
CAS
PubMed
Google Scholar
Des Roches A, Paradis L, Menardo JL: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997, 99: 450-3. 10.1016/S0091-6749(97)70069-1.
Article
CAS
PubMed
Google Scholar
Cools M, Van Bever HP, Weyler JJ, Stevens WJ: Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen. Allergy. 2000, 55: 69-73. 10.1034/j.1398-9995.2000.00191.x.
Article
CAS
PubMed
Google Scholar
Moller C, Dreborg S, Ferdousi HA: Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol. 2002, 109: 251-6. 10.1067/mai.2002.121317.
Article
PubMed
Google Scholar
Johnstone DE, Dutton A: The value of hyposensitization therapy for bronchial asthma in children--a 14-year study. Pediatrics. 1968, 42: 793-802.
CAS
PubMed
Google Scholar
Adkinson NF, Eggleston PA, Eney D: A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med. 1997, 336: 324-31. 10.1056/NEJM199701303360502.
Article
CAS
PubMed
Google Scholar
Cantani A, Arcese G, Lucenti P: A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Investig Allergol Clin Immunol. 1997, 7: 90-7.
CAS
PubMed
Google Scholar
Hedlin G, Wille S, Browaldh L: Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy. J Allergy Clin Immunol. 1999, 103: 609-14. 10.1016/S0091-6749(99)70232-0.
Article
CAS
PubMed
Google Scholar
Portnoy JM: Immunotherapy for asthma: unfavorable studies. Ann Allergy Asthma Immunol. 2001, 87 (1 Suppl 1): 28-32. 10.1016/S1081-1206(10)62191-6.
Article
CAS
PubMed
Google Scholar
Abramson MJ, Puy RM, Weiner JM: Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995, 151: 969-74.
CAS
PubMed
Google Scholar
Ross RN, Nelson HS, Finegold I: Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther. 2000, 22: 329-41. 10.1016/S0149-2918(00)80037-5.
Article
CAS
PubMed
Google Scholar
Center JG, Shuller N, Zeleznick LD: Stability of antigen E in commercially prepared ragweed pollen extracts. Dev Biol Stand. 1975, 29: 114-22.
CAS
PubMed
Google Scholar
Ayuso R, Rubio M, Herrera T: Stability of Lolium perenne extract. Ann Allergy. 1984, 53: 426-31.
CAS
PubMed
Google Scholar
Vijay HM, Young NM, Bernstein IL: Studies on Alternaria allergens. VI. Stability of the allergen components of Alternaria tenuis extracts under a variety of storage conditions. Int Arch Allergy Appl Immunol. 1987, 83: 325-8. 10.1159/000234316.
Article
CAS
PubMed
Google Scholar
Niemeijer NR, Kauffman HF, van Hove W: Effect of dilution, temperature, and preservatives on the long-term stability of standardized inhalant allergen extracts. Ann Allergy Asthma Immunol. 1996, 76: 535-40. 10.1016/S1081-1206(10)63274-7.
Article
CAS
PubMed
Google Scholar
Liu T, Lin Y: The epitope stability of group 1 and group 2 allergens in mite extracts. Ann Allergy Asthma Immunol. 1998, 80: 177-83. 10.1016/S1081-1206(10)62952-3.
Article
CAS
PubMed
Google Scholar
Soldatova LN, Paupore EJ, Burk SH: The stability of house dust mite allergens in glycerinated extracts. J Allergy Clin Immunol. 2000, 105: 482-8. 10.1067/mai.2000.104549.
Article
CAS
PubMed
Google Scholar
Savolainen J, Broberg A: Crossreacting IgE antibodies to Pityrosporum ovale and Candida albicans in atopic children. Clin Exp Allergy. 1992, 22: 469-74. 10.1111/j.1365-2222.1992.tb00149.x.
Article
CAS
PubMed
Google Scholar
Nelson HS: The effect of preservatives and dilution on the deterioration of Russian thistle (Salsola pestifer), a pollen extract. J Allergy Clin Immunol. 1979, 63: 417-25. 10.1016/0091-6749(79)90216-1.
Article
CAS
PubMed
Google Scholar
Nelson HS: Effect of preservatives and conditions of storage on the potency of allergy extracts. J Allergy Clin Immunol. 1981, 67: 64-9. 10.1016/0091-6749(81)90047-6.
Article
CAS
PubMed
Google Scholar
Nelson HS, Ikle D, Buchmeier A: Studies of allergen extract stability: the effects of dilution and mixing. J Allergy Clin Immunol. 1996, 98: 382-8. 10.1016/S0091-6749(96)70162-8.
Article
CAS
PubMed
Google Scholar
Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC: Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol. 2001, 87 (1 Suppl 1): 47-55. 10.1016/S1081-1206(10)62195-3.
Article
CAS
PubMed
Google Scholar
Malling HJ: Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2001, 1: 43-6.
Article
CAS
PubMed
Google Scholar
Bernstein DI, Wanner M, Borish L, Liss GM: Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004, 113: 1129-36. 10.1016/j.jaci.2004.02.006.
Article
PubMed
Google Scholar
Aaronson DW, Gandhi TK: Incorrect allergy injections: allergists' experiences and recommendations for prevention. J Allergy Clin Immunol. 2004, 113: 1117-21. 10.1016/j.jaci.2004.01.756.
Article
PubMed
Google Scholar
Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA: Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol. 1993, 92: 6-15. 10.1016/0091-6749(93)90030-J.
Article
CAS
PubMed
Google Scholar
Haselden BM, Kay AB, Larche M: Peptide-mediated immune responses in specific immunotherapy. Int Arch Allergy Immunol. 2000, 122: 229-37. 10.1159/000024403.
Article
CAS
PubMed
Google Scholar
Oldfield WL, Kay AB, Larche M: Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol. 2001, 167: 1734-9.
Article
CAS
PubMed
Google Scholar
Muller U, Akdis CA, Fricker M: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998, 101: 747-54. 10.1016/S0091-6749(98)70402-6.
Article
CAS
PubMed
Google Scholar
Larche M, Haselden BM, Oldfield WL: Mechanisms of T cell peptide epitope-dependent late asthmatic reactions. Int Arch Allergy Immunol. 2001, 124: 272-5. 10.1159/000053730.
Article
CAS
PubMed
Google Scholar
Tighe H, Takabayashi K, Schwartz D: Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol. 2000, 106: 124-34. 10.1067/mai.2000.107927.
Article
CAS
PubMed
Google Scholar
Nelson HS: Immunotherapy for inhalant allergens. Middleton's allergy: principles and practice. Edited by: Adkinson NF Jr, Yunginger JW, Busse WW, et al. 2003, Philadelphia: C. V. Mosby, 1455-74. 6
Google Scholar